EPISODE · May 16, 2018 · 18 MIN
Bull vs Bear: GlaxoSmithKline
from Investors' Chronicle
GlaxoSmithKline (GSK) is a company that divides opinion and therefore an ideal candidate for the IC's Bull vs Bear series. In this episode, Simon Gergel from the Merchants Trust argues the bull case against the ICs pharma specialist (and GSK sceptic), Megan Boxall.Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.
What this episode covers
GlaxoSmithKline (GSK) is a company that divides opinion and therefore an ideal candidate for the IC's Bull vs Bear series. In this episode, Simon Gergel from the Merchants Trust argues the bull case against the ICs pharma specialist (and GSK sceptic), Megan Boxall.Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.
NOW PLAYING
Bull vs Bear: GlaxoSmithKline
No transcript for this episode yet
Similar Episodes
May 8, 2026 ·52m
May 1, 2026 ·50m
Apr 22, 2026 ·26m
Apr 6, 2026 ·51m
Mar 13, 2026 ·53m
Mar 7, 2026 ·53m